Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

NCT07292298 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Rectal Adenocarcinoma
Rectal Cancer

Interventions

RADIATION: High Rare Dose Rectal Brachytherapy Boost

Sponsor

University of Colorado, Denver

Collaborators

[object Object]